AcquiredStartups
Home/North America/Healthtech & bio
Asset purchase · Healthtech & bio · United States

Therabody buys the intellectual property of Embr Labs, maker of a hot-flash cooling wristband

The Theragun maker bought Embr's patented thermal technology and research to build menopause products, but not the company itself: Embr Labs keeps selling and supporting the Embr Wave 2.

ASAcquired deals deskNorth America18 November 2026 · 3 min read
Therabody acquires Embr Labs
Image: Therabody (press release)

Therabody, the wellness technology company behind the Theragun massage device, said on November 18, 2026 that it had acquired the intellectual property portfolio of Embr Labs. Embr, which was founded at the Massachusetts Institute of Technology, makes the Embr Wave, a wristband that cools or warms the skin to help with hot flashes and sleep. Therabody did not disclose what it paid.

The deal covers Embr's technology rather than the company. According to Therabody, it brings Embr's patented thermal technology, which Therabody described as clinically validated, and Embr's research under Therabody's ownership. Therabody did not say it was buying Embr Labs as a business, and the release told owners of the current Embr Wave 2 to keep going to Embr Labs for orders and product support. It did not say whether any Embr employees would move to Therabody.

Therabody said it would use the technology for women's health, starting with menopause, and would lead the next stage of clinical research and product development. It gave no timeline for new products.

What Embr Labs built

The Embr Wave is worn on the inside of the wrist, an area with many nerves that sense temperature, and delivers bursts of cooling or warmth there. When Embr raised money in 2019 it said its core invention was a set of patented thermal waveforms, timed temperature changes that made cooling possible in a small device while using less power.

Embr traces its origins to 2013, when its founders began asking questions about personal temperature control. Prototypes and field tests followed in 2015. The first version of the Wave launched on Kickstarter in 2017, raising more than $600,000, and the consumer product launched in 2018. By 2019 the company said it had sold tens of thousands of devices, and its website now says its products are used in 177 countries.

The Wave won a TIME Best Inventions honourable mention in 2018, the AARP Innovator in Aging prize in 2019, a Men's Health Sleep Award in 2020, an iF World Design Guide award in 2021 and the National Sleep Foundation's Sleep Tech Award in 2023.

“From developing the original Embr Wave to pioneering AI-driven hot flash prediction, our goal has always been about one thing: delivering real, immediate relief to the people who need it most.”Matt Smith, CTO and Co-founder, Embr Labs
Funding historyTotal raised n/a
2019Series BDigiTx Partners$6m

The research Therabody is buying

Therabody pointed to Embr's published studies as a large part of the value. In a 2025 paper in the journal Psychophysiology, Embr and researchers at the University of Massachusetts Amherst described an AI model that detected 82% of menopausal hot flashes an average of 17 seconds before the women noticed them. Therabody said that work could lead to a device that starts cooling before a hot flash sets in.

In a separate randomised crossover study cited by Therabody, two-thirds of women with menopausal hot flashes said the Wave improved their thermal comfort and helped them fall back asleep after waking at night. Therabody cited a 2026 meta-analysis estimating that hot flashes and night sweats affect as many as three in four women during the menopause transition.

Why Therabody is buying

Therabody was founded in 2016 by Dr. Jason Wersland. Besides the Theragun it sells JetBoots, TheraFace, SmartGoggles and TheraCup, and runs in-person services under the Reset by Therabody name. It has funded research on women's health since 2022 and has committed more than $1 million, including studies with the University of Michigan on pain in postmenopausal women and with Georgia State University on Black female runners. In 2025 it launched Therabody for Her, and its scientists published a review of how menopause affects the body's temperature regulation.

For Embr, Therabody said, the deal provides a partner with the engineering, research, manufacturing and global distribution needed to reach more women. Matt Smith, Embr's chief technology officer and a co-founder, said Therabody would carry the company's next-generation temperature technology forward. Pamela Peeke, Embr's former chief medical officer, now sits on Therabody's Scientific Advisory Board.

The founders and the funding

Embr Labs was started by three engineers in a lab at MIT, according to its 2019 funding announcement. Its name stands for Environment-Mind-Body-Resonance.

In September 2019 the company raised a $6 million Series B round led by DigiTx Partners, with Safar Partners, Joyance Partners, Bose Ventures and PBJ Capital taking part. Elizabeth Gazda was chief executive at the time, and the company said the money would go towards new uses for thermal wellness and the next generation of its technology. Therabody's announcement listed DigiTx Partners, Esplanade Ventures and Ghost Tree Partners as Embr's backers. Embr has not disclosed how much it raised in total.

Sources